ICD-10 Logo
ICDxICD-10 Medical Coding
ICD-10 Logo
ICDxICD-10 Medical Coding
ICD 10 CodesDiagnoses
ICD 10 CodesDiagnoses
ICD-10 Logo
ICDxICD-10 Medical Coding

Comprehensive ICD-10-CM code reference with AI-powered search capabilities.

© 2025 ICD Code Compass. All rights reserved.

Browse

  • All Chapters
  • All Categories
  • Diagnoses

Tools

  • AI Code Search
ICD-10-CM codes are maintained by the CDC and CMS. This tool is for reference purposes only.
v1.0.0
ICD-10 Guide
ICD-10 CodesE11.69

E11.69

Billable

Type 2 diabetes mellitus with other specified complication

BILLABLE STATUSYes
IMPLEMENTATION DATEOctober 1, 2015
LAST UPDATED09/05/2025

Code Description

ICD-10 E11.69 is a billable code used to indicate a diagnosis of type 2 diabetes mellitus with other specified complication.

Key Diagnostic Point:

E11.69 refers to Type 2 diabetes mellitus with other specified complications that are not classified under more specific codes. Type 2 diabetes is characterized by insulin resistance and relative insulin deficiency, leading to chronic hyperglycemia. Patients may experience a range of complications, including neuropathy, retinopathy, nephropathy, and cardiovascular diseases. The 'other specified complication' designation allows for the inclusion of complications that do not fit neatly into established categories, such as skin infections, gastrointestinal issues, or other metabolic disturbances. Management of Type 2 diabetes often involves lifestyle modifications, oral hypoglycemic agents, and sometimes insulin therapy, depending on the severity of the disease and the patient's response to treatment. Regular monitoring of HbA1c levels is crucial for assessing long-term glycemic control, with targets typically set below 7% for most adults. The complexity of coding E11.69 arises from the need for precise documentation of the specific complications present, as well as the potential for overlapping conditions that may require careful differentiation.

Code Complexity Analysis

Complexity Rating: Medium

Medium Complexity

Complexity Factors

  • Variety of possible complications that can be associated with Type 2 diabetes.
  • Need for precise documentation to specify the nature of the 'other specified complication'.
  • Potential overlap with other diabetes-related codes.
  • Variability in treatment approaches based on individual patient factors.

Audit Risk Factors

  • Inadequate documentation of the specific complications.
  • Failure to link complications directly to diabetes management.
  • Misclassification of complications that may belong to other codes.
  • Inconsistent HbA1c reporting that does not align with treatment plans.

Specialty Focus

Medical Specialties

Endocrinology

Documentation Requirements

Detailed patient history, including HbA1c levels, treatment plans, and specific complications.

Common Clinical Scenarios

Patients presenting with uncontrolled blood sugar levels and associated complications.

Billing Considerations

Endocrinologists must ensure that all complications are documented clearly to support the use of E11.69.

Primary Care

Documentation Requirements

Comprehensive records of patient visits, including lifestyle modifications and medication adjustments.

Common Clinical Scenarios

Routine follow-ups for diabetes management and monitoring of complications.

Billing Considerations

Primary care providers should document all relevant patient education and management strategies to justify coding.

Coding Guidelines

Inclusion Criteria

Use E11.69 When
  • According to ICD
  • 10 coding guidelines, E11
  • 69 should be used when a patient with Type 2 diabetes has a complication that is not classified elsewhere
  • Coders must ensure that the documentation supports the diagnosis and that the complication is clearly specified

Exclusion Criteria

Do NOT use E11.69 When
  • Exclusion criteria include conditions that are specifically coded elsewhere

Related ICD-10 Codes

Related CPT Codes

99213CPT Code

Established patient office visit, Level 3

Clinical Scenario

Used for follow-up visits for diabetes management.

Documentation Requirements

Document the patient's diabetes management plan and any complications.

Specialty Considerations

Endocrinologists may require more detailed documentation compared to primary care.

ICD-10 Impact

Diagnostic & Documentation Impact

Enhanced Specificity

ICD-10 Improvements

The transition to ICD-10 has allowed for more specific coding of diabetes-related complications, improving the accuracy of patient records and facilitating better management of diabetes care. E11.69 provides flexibility for coders to capture complications that do not fit into predefined categories, enhancing clinical documentation.

ICD-9 vs ICD-10

The transition to ICD-10 has allowed for more specific coding of diabetes-related complications, improving the accuracy of patient records and facilitating better management of diabetes care. E11.69 provides flexibility for coders to capture complications that do not fit into predefined categories, enhancing clinical documentation.

Reimbursement & Billing Impact

The transition to ICD-10 has allowed for more specific coding of diabetes-related complications, improving the accuracy of patient records and facilitating better management of diabetes care. E11.69 provides flexibility for coders to capture complications that do not fit into predefined categories, enhancing clinical documentation.

Resources

Clinical References

  • •
    American Diabetes Association
  • •
    ICD-10-CM Official Guidelines for Coding and Reporting

Coding & Billing References

  • •
    American Diabetes Association
  • •
    ICD-10-CM Official Guidelines for Coding and Reporting

Frequently Asked Questions

What are the common complications associated with Type 2 diabetes?

Common complications include neuropathy, retinopathy, nephropathy, cardiovascular diseases, and skin infections. Each of these may require specific documentation and coding.

How often should HbA1c levels be monitored in patients with Type 2 diabetes?

HbA1c levels should typically be monitored every 3 to 6 months, depending on the patient's treatment plan and stability of their blood glucose levels.